Your browser doesn't support javascript.
loading
A reverse transcriptase-mediated ribosomal RNA depletion (RTR2D) strategy for the cost-effective construction of RNA sequencing libraries.
Zeng, Zongyue; Huang, Bo; Wang, Xi; Fan, Jiaming; Zhang, Bo; Yang, Lijuan; Feng, Yixiao; Wu, Xiaoxing; Luo, Huaxiu; Zhang, Jing; Zhang, Meng; He, Fang; Mao, Yukun; Pakvasa, Mikhail; Wagstaff, William; Li, Alexander J; Liu, Bin; Ding, Huimin; Zhang, Yongtao; Niu, Changchun; Wu, Meng; Zhao, Xia; Wolf, Jennifer Moriatis; Lee, Michael J; Huang, Ailong; Luu, Hue H; Haydon, Rex C; He, Tong-Chuan.
Afiliación
  • Zeng Z; Ministry of Education Key Laboratory of Diagnostic Medicine, the Molecular Medicine Laboratory, and the School of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
  • Huang B; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Wang X; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Fan J; Department of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330031, China.
  • Zhang B; Ministry of Education Key Laboratory of Diagnostic Medicine, the Molecular Medicine Laboratory, and the School of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
  • Yang L; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Feng Y; Ministry of Education Key Laboratory of Diagnostic Medicine, the Molecular Medicine Laboratory, and the School of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
  • Wu X; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Luo H; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Zhang J; Key Laboratory of Orthopaedic Surgery of Gansu Province, and Departments of Orthopaedic Surgery and Obstetrics and Gynecology, The First and Second Hospitals of Lanzhou University, Lanzhou 730030, China.
  • Zhang M; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • He F; Key Laboratory of Orthopaedic Surgery of Gansu Province, and Departments of Orthopaedic Surgery and Obstetrics and Gynecology, The First and Second Hospitals of Lanzhou University, Lanzhou 730030, China.
  • Mao Y; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Pakvasa M; Departments of Breast Surgery, Gastrointestinal Surgery, Obstetrics and Gynecology, and Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Wagstaff W; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Li AJ; Departments of Breast Surgery, Gastrointestinal Surgery, Obstetrics and Gynecology, and Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Liu B; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Ding H; Department of Burn and Plastic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Zhang Y; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Niu C; Departments of Breast Surgery, Gastrointestinal Surgery, Obstetrics and Gynecology, and Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Wu M; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Zhao X; Department of Orthopaedic Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
  • Wolf JM; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Lee MJ; Departments of Breast Surgery, Gastrointestinal Surgery, Obstetrics and Gynecology, and Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Huang A; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • Luu HH; Department of Orthopaedic Surgery, The Affiliated Zhongnan Hospital of Wuhan University, Wuhan 430072, China.
  • Haydon RC; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  • He TC; Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, Chicago, IL 60637, USA.
J Adv Res ; 24: 239-250, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32373357
ABSTRACT
RNA sequencing (RNA-seq)-based whole transcriptome analysis (WTA) using ever-evolving next-generation sequencing technologies has become a primary tool for coding and/or noncoding transcriptome profiling. As WTA requires RNA-seq data for both coding and noncoding RNAs, one key step for obtaining high-quality RNA-seq data is to remove ribosomal RNAs, which can be accomplished by using various commercial kits. Nonetheless, an ideal rRNA removal method should be efficient, user-friendly and cost-effective so it can be adapted for homemade RNA-seq library construction. Here, we developed a novel reverse transcriptase-mediated ribosomal RNA depletion (RTR2D) method. We demonstrated that RTR2D was simple and efficient, and depleted human or mouse rRNAs with high specificity without affecting coding and noncoding transcripts. RNA-seq data analysis indicated that RTR2D yielded highly correlative transcriptome landscape with that of NEBNext rRNA Depletion Kit at both mRNA and lncRNA levels. In a proof-of-principle study, we found that RNA-seq dataset from RTR2D-depleted rRNA samples identified more differentially expressed mRNAs and lncRNAs regulated by Nutlin3A in human osteosarcoma cells than that from NEBNext rRNA Depletion samples, suggesting that RTR2D may have lower off-target depletion of non-rRNA transcripts. Collectively, our results have demonstrated that the RTR2D methodology should be a valuable tool for rRNA depletion.
Palabras clave

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Health_economic_evaluation Idioma: En Revista: J Adv Res Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Health_economic_evaluation Idioma: En Revista: J Adv Res Año: 2020 Tipo del documento: Article País de afiliación: China